( March 16, 2012) -- Brushing aside opposition from Congress, states’ attorneys general and pharmacists’ groups, the FTC appears unlikely to block the controversial $29 billion merger of mega-prescription benefit managers Express- Scripts Inc. and Medco Health Solutions Inc., although it could impose some conditions on the deal....